In the Boardroom
Refine Search
Pharmaceutical
Boehringer Ingelheim today announced that Dr Christopher Corsico, senior vice president, corporate division Medicine and chief medical officer, will be leaving the German family-owned pharma major to pursue his career outside of the company effective December 31, 2018. 11 September 2018
Pharmaceutical
Sweden-based Medivir today revealed it has appointed Linda Basse as Chief Medical Officer effective October 1, 2018. 10 September 2018
Pharmaceutical
Ironshore Pharmaceuticals, a wholly-owned subsidiary of Canada’s Highland Therapeutics, has appointed Scott Evangelista to the position of president and chief operating officer (COO). 7 September 2018
Biotechnology
Rheos Medicines, a Boston, USA, biotech developing novel medicines that modulate metabolic pathways in immune cells to treat disease, has poached an experienced big pharma R&D leader from Roche to be its new chief executive. 6 September 2018
Pharmaceutical
French drugmaker Ipsen has named Asad Mohsin Ali as general manager of its UK and Ireland affiliate. 4 September 2018
Pharmaceutical
London-listed Arix Bioscience has announced a change to its executive team which will see current chief executive Joe Anderson moved to the role of chief investment officer. 4 September 2018
Pharmaceutical
Switzerland-based Tillotts Pharma, part of the Japanese Zeria Group, has announced that Karima Boubekeur is joining the company to take on the newly-created role of global head of innovation. 3 September 2018
Generics
With effect from September 1, Peter Goldschmidt succeeded Claudio Albrecht as the chief executive of Stada Arzneimittel. 3 September 2018
Pharmaceutical
EMD Serono, the biopharmaceutical business of Merck KGaA in the USA and Canada, today announced that Rehan Verjee has been appointed president of EMD Serono and global head of innovative medicine franchises of Merck. 31 August 2018
Pharmaceutical
Indianapolis, USA-based Eli Lilly has announced that Anne White is to become president of Lilly Oncology and senior vice president of Lilly, effective September 1, 2018. 31 August 2018
Biotechnology
The senior vice president of US commercial operations at Amgen has left to join another US biotech major. 29 August 2018
Pharmaceutical
US pharma major Bristol-Myers Squibb yesterday announced that Christopher Boerner has been appointed executive vice president and chief commercial officer, effective immediately. 29 August 2018
Pharmaceutical
Vertex Pharmaceuticals today announced that Ludovic Fenaux has been appointed senior vice president, international commercial operations with responsibility for commercial activities outside of the USA and Canada, which includes overseeing offices and operations across Europe, Australia and Latin America. 23 August 2018
Biotechnology
Rare diseases specialist Swedish Orphan Biovitrum has appointed Anne Marie de Jonge Schuermans as head of its new Technical Operations organization, bringing together Sobi’s manufacturing operations/biological development and supply, quality, supply chain, procurement and environment and safety operations. 22 August 2018
Biotechnology
Allegro Opthalmics has announced the hiring of a new chief executive, former chief medical officer Vicken Karageozian. 21 August 2018
Biotechnology
UK biopharma firm PureTech Health has announced the appointment of Dr Steven Paul, as chief executive of its affiliate, Karuna Pharmaceuticals. 15 August 2018
Biotechnology
Following the resignation of Dr Andrew Cheng, chief medical officer of US biotech major Gilead Sciences, the company has announced two promotions. 15 August 2018
Biotechnology
Namir Hassan has been named chief scientific officer of Zelluna Immunotherapy, a privately-held Norwegian biotech specializing in T-cell receptor (TCR) immunotherapies. 13 August 2018
Pharmaceutical
Alzheon, a privately-held American biopharmaceutical company, has announced its hiring of former IVAX president Neil Flanzraich as vice chairman of the board. 6 August 2018
Biotechnology
CAR-T therapy company Cellectis announced on Friday that Stefan Scherer, vice president and global lead for early development and innovation at Novartis, would join the company in a leadership role. 3 August 2018
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze